Documented prevalence of HIV type 1 antiretroviral transmitted drug resistance in Ireland from 2004 to 2008

Cillian F. De Gascun, Allison Waters, Ciara Regan, Jane O'Halloran, Gillian Farrell, Suzie Coughlan, Colm Bergin, William G. Powderly, William W. Hall

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

HIV-1-infected individuals with transmitted HIV drug resistance (TDR) begin antiretroviral therapy (ART) with a lower genetic barrier to resistance and a higher risk of both virological failure and of developing further resistance. TDR surveillance informs HIV-1 public health strategies and first line ART. TDR has not been studied nationally in an Irish population. This study includes all new HIV diagnoses from January 2004 to September 2008 from the National Virus Reference Laboratory, University College Dublin. HIV-1 protease and reverse transcriptase sequences were generated, and resistance mutations identified using the Siemens TRUGENE HIV-1 Genotyping System. Subtypes were determined using web-based genotyping tools. The study comprised 1579 patients. There were 305 new diagnoses in 2004 (173 male; 132 female), 298 in 2005 (175M; 123F), 321 in 2006 (197M; 124F), 297 in 2007 (184M; 113F), and 358 (235M; 123F) in 2008. HIV-1 RNA was sequenced from 158/305 patients in 2004, 199/298 in 2005, 225/321 in 2006, 203/297 in 2007, and 275/358 in 2008. The overall TDR rate was 6.3%, peaking in 2006 at 10.4% and declining to 5.3% in 2008. The majority of TDR was seen in Irish born individuals with HIV-1 subtype B infection. The TDR rate in Ireland is comparatively low. Thus, a health technology assessment is required to ascertain the most cost effective use of genotypic antiretroviral resistance testing (GART) in the future: the current approach of performing baseline GART on all new diagnoses, or perhaps a more targeted approach that focuses on patients commencing nonnucleoside reverse transcriptase inhibitor (NNRTI)-based ART.

Original languageEnglish
Pages (from-to)276-281
Number of pages6
JournalAIDS research and human retroviruses
Volume28
Issue number3
DOIs
StatePublished - Mar 1 2012
Externally publishedYes

Fingerprint Dive into the research topics of 'Documented prevalence of HIV type 1 antiretroviral transmitted drug resistance in Ireland from 2004 to 2008'. Together they form a unique fingerprint.

  • Cite this